J Med Virol
. 2020 Jul 7.
doi: 10.1002/jmv.26266. Online ahead of print.
A Retrospective Review of Memantine Use and COVID-19-associated Mortality From a National Database
Moon Ho Park 1 , Do Young Kwon 1
Affiliations
- PMID: 32633865
- DOI: 10.1002/jmv.26266
Abstract
We read with interest the recent papers by Brenner and Cimolai regarding the therapeutic potential of memantine for coronavirus disease (COVID-19). In this retrospective, we investigated the relationship between treatment with memantine and COVID-19-associated mortality in 5,726 patients with COVID-19, of whom 140 had died. Our analysis revealed no association between memantine treatment and mortality in patients with COVID-19. However, we must explore all feasible options for preventing and treating COVID-19 due to the current lack of licensed vaccines or therapeutics for the disease. This article is protected by copyright. All rights reserved.
Keywords: Antiviral agents < Disease control; Coronavirus < Virus classification; Drug specificity < Antiviral agents.